The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in
Advertising and Marketing, Black Markets, Consumer Protection, Dietary Supplements and Herbal Remedies, Drugs (Pharmaceuticals), Food and Drug Administration, Health and Human Services Department, Kennedy, Robert F Jr, Longevity, Recalls and Bans of Products, Regulation and Deregulation of Industry, Trump, Donald J, United States